As the authors report in vitro targeting efficacy tested against three pancreatic cancer cell lines (PANC-1, AsPC-1, and MIA Paca2) with variable epidermal growth factor receptor (EGFR) expression, and showed that gold uptake correlated with EGFR expression. This evidence concerns the gene EGFR and familial pancreatic carcinoma.